Plain-English translation of NCT06976619 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
Researchers at Mayo Clinic are studying how a medication called liraglutide affects the insulin-producing cells in your pancreas. This medication is already used to treat diabetes, but scientists want to understand exactly how it works — especially whether it works differently depending on whether you have type 1 or type 2 diabetes. By learning more about these details, they hope to improve diabetes treatments.
While this medication is known to help with blood sugar control, doctors don't fully understand how it influences the pancreas cells that make insulin and glucagon. This study will fill that gap and could lead to better and more targeted treatments for both types of diabetes.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will be randomly assigned to receive either the medication or a placebo (a non-active saline injection) that you will inject yourself daily. The study includes visits to Mayo Clinic where researchers will monitor your blood sugar, take blood samples to study your pancreas cells, and check how you are doing. Your participation will help scientists understand how this treatment affects the cells that control your blood sugar.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States